Skybiotech Healthcare ratifies name change compliance, approves FY26 accounts

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Skybiotech Healthcare ratified rectification of SEBI LODR non-compliance regarding its name change from Kapil Cotex
  • Audited standalone and consolidated financial statements for FY26 were adopted by shareholders
  • M/s. SPD & Associates appointed as statutory auditor replacing previous engagement
  • Mr. Prakashchandra Rathi re-appointed as director retiring by rotation
powered bylight_fuzz_icon
52301264

*this image is generated using AI for illustrative purposes only.

Skybiotech Healthcare ratified the rectification of a procedural non-compliance related to its name change from Kapil Cotex Limited during its 43rd Annual General Meeting (AGM) held on September 30, 2026. The meeting also adopted the audited financial statements for FY26 and appointed a new statutory auditor.

Name change compliance rectified

The company had changed its name from Kapil Cotex Limited to Skybiotech Healthcare Limited via a Special Resolution at the AGM held on September 25, 2025. However, the certificate from a Practicing Chartered Accountant confirming compliance with Regulation 45(1) of the SEBI LODR Regulations was inadvertently not circulated with the notice for that approval.

To address this oversight, the company furnished an undertaking to BSE Limited to rectify the non-compliance under Regulation 45(3). During the current AGM, the Chairman placed the required CA certificate before the members. The shareholders took note of the certificate and ratified the actions taken by the company, thereby approving the rectification of the procedural lapse.

Key resolutions passed

Shareholders adopted both standalone and consolidated audited financial statements along with the reports of the Board and Auditor for the year ended March 31, 2026. Additionally, Mr. Prakashchandra Rathi (DIN: 01393087) was re-appointed as a director, retiring by rotation and offering himself for re-appointment as he is eligible.

The appointment of M/s. SPD & Associates, Chartered Accountants (FRN: 139118W), marks a change in the statutory audit engagement for the company. This resolution was passed as an ordinary resolution by the members present.

Resolution Type Matter Status
Ordinary Adoption of Standalone Audited Financial Statements (FY26) Approved
Ordinary Adoption of Consolidated Audited Financial Statements (FY26) Approved
Ordinary Re-appointment of Mr. Prakashchandra Rathi as Director Approved
Ordinary Appointment of SPD & Associates as Statutory Auditor Approved
Ordinary Ratification of name change compliance rectification Approved

Meeting proceedings and attendance

The AGM commenced at 11:00 am at the company's registered office in Chh. Sambhaji Nagar, Maharashtra, and concluded at 12:40 pm on September 30, 2026. The Company Secretary reported that as on the cut-off date of September 23, 2026, there were 649 members in the company. With seven members present in person, the requisite quorum under Section 103 of the Companies Act, 2013, was satisfied.

Directors present included Managing Director Poonam Prakash Rathi, Director and CFO Prakashchandra Rathi, Independent Director Yogesh Chandak, and Non-Executive Director Vijay Chitlange. Leave of absence was granted to Independent Directors Mr. Rakesh Ramswaroop Somani and Jagdish Manohar Mantri due to pre-occupation.

Historical Stock Returns for Skybiotech Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-0.97%-2.50%-15.77%0.0%+277.42%

How will the transition from Kapil Cotex to Skybiotech Healthcare impact the company's strategic direction and revenue mix in the upcoming fiscal years?

What specific changes in audit scope or methodology can investors expect with the appointment of SPD & Associates as the new statutory auditor?

Given the low shareholder attendance and quorum satisfaction, how might this affect future corporate governance ratings or institutional investor confidence?

like16
dislike

Skybiotech Healthcare schedules 43rd AGM for September 30, 2026

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Skybiotech Healthcare holds its 43rd AGM on September 30, 2026, in Aurangabad
  • Shareholders to adopt standalone and consolidated financials for FY26
  • M/s. SPD & Associates appointed as statutory auditors for five years
  • E-voting open from September 26 to 29, 2026, via NSDL platform
powered bylight_fuzz_icon
50142978

*this image is generated using AI for illustrative purposes only.

Skybiotech Healthcare Limited will hold its 43rd Annual General Meeting on Wednesday, September 30, 2026. The physical meeting is scheduled to begin at 11:00 am at the company’s registered office in Chh. Sambhaji Nagar (Aurangabad), Maharashtra.

The meeting agenda covers ordinary business items for the financial year ended March 31, 2026. Shareholders will consider and adopt both the Audited Standalone and Consolidated Financial Statements, along with the Board Report and Auditors’ Reports.

Key Agenda Items

The notice outlines specific resolutions for shareholder approval:

  • Adoption of Financials: Approval of standalone and consolidated financial results for FY26.
  • Director Re-appointment: Re-appointment of Mr. Prakashchandra Rathi, who retires by rotation and offers himself for re-election.
  • Statutory Auditor Appointment: Appointment of M/s. SPD & Associates, Chartered Accountant (FRN: 139118W), as statutory auditors. They are proposed to hold office for five consecutive years, from the conclusion of this AGM until the conclusion of the 48th AGM in FY2031.

Voting and Logistics

The company has dispatched the AGM notice and Annual Report electronically to members who registered their email addresses with the Registrar and Transfer Agent or Depository Participants. The record date for determining voting eligibility is August 28, 2026.

Event Date Details
Cut-Off Date for Notice August 28, 2026 Register of Members/Beneficial Owners
Book Closure Period September 23–30, 2026 No trading during this period
E-Voting Period September 26–29, 2026 Remote e-voting via NSDL
AGM Date September 30, 2026 Physical meeting at 11:00 am

Shareholders holding shares as on the cut-off date may cast their votes electronically through the National Securities Depository Limited (NSDL) platform. The e-voting module will be active from September 26, 2026, at 10:00 am until September 29, 2026, at 5:00 pm. Members who vote remotely will not be eligible to vote again via poll paper at the physical meeting.

SM Dhumal & Associates, Practicing Company Secretary, has been appointed as the scrutinizer to ensure a fair and transparent e-voting process. Results will be declared on or after the AGM and posted on the company’s website within two days.

Historical Stock Returns for Skybiotech Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-0.97%-2.50%-15.77%0.0%+277.42%

How might the re-appointment of Mr. Prakashchandra Rathi influence Skybiotech's strategic direction and governance stability in FY27?

What are the potential market reactions to the appointment of SPD & Associates as statutory auditors for a five-year term ending in 2031?

Given the book closure period from September 23–30, how is this expected to impact short-term trading volume and liquidity for Skybiotech shares?

like19
dislike

More News on Skybiotech Healthcare

1 Year Returns:0.00%